🇰🇷 Hanmi Pharm

30-day score trend

📊 Quant score trend

Last 30d quant score (PER/PBR/ROE/debt/margin/growth sector percentile)

PER 40.8 / PBR 5.27 / ROE 14.5% / 부채비율 50% / 이익률 16.7% / 매출성장 +3.5% / 이익성장 +33.3%

Not a buy or sell signal. Informational only.

📊 Latest earnings — 2026-06-30

Informational — not a buy signal. Source: DART

🕸️ Metrics radar

Informational — 5 axes are 0-100 percentile, compared to sector average

Market regime — 🇰🇷 KR (Korea)

BULL "이번 주 +10.8%, 추세는 살아 있습니다. 분위기는 들떠 있어요."

📈 7-day price

📋 Recent filings (DART)

• 08-24 투자판단관련주요경영사항
• 08-21 [기재정정]투자판단관련주요경영사항
• 08-21 [기재정정]투자판단관련주요경영사항

Source: DART (Korean electronic disclosure). Reference only.

📰 Recent news

• 계약금 2위·10년 만의 재회…한미, 의미있는 기술수출 낭보

  08-24 · Naver

• 외국인들, 삼성그룹주 던졌다…100조 넘는 주주환원책에 실망한 이유는

  08-24 · Naver

• "기술 탐난다"…K-바이오에 지갑 여는 빅파마들

  08-24 · Naver

Source: Naver. Not Tradory's opinion.

🔎 Compare info

Click a button to see database-backed metrics. Informational only, not buy or sell signals.

ⓘ This compares public financial and market data. Not a buy or sell opinion.